Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cornelia von Hagens

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Forschende Komplementarmedizin (2006)|June 15, 2007
[Replacing the hormone replacement therapy]Cornelia von Hagens
MMW Fortschritte Der Medizin|November 26, 2008
[Alternative therapies for menopausal women]Cornelia von Hagens, Bettina Reinhard-Hennch, Thomas Strowitzki
Gynakologisch-Geburtshilfliche Rundschau|October 28, 2006
[Complementary and alternative therapies for climacteric symptoms]Bettina Reinhard-Hennch, Thomas Strowitzki, Cornelia von Hagens
European Journal of Clinical Pharmacology|September 25, 2014
Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancerTherese Ericsson, Antje Blank, Cornelia von Hagens, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 4, 2015
Developing and implementing a complex Complementary and Alternative (CAM) nursing intervention for breast and gynecologic cancer patients undergoing chemotherapy--report from the CONGO (complementary nursing in gynecologic oncology) studyNadja Klafke, Cornelia Mahler, Cornelia von Hagens, et al.
Journal of Assisted Reproduction and Genetics|September 9, 2011
Resilience in infertile couples acts as a protective factor against infertility-specific distress and impaired quality of lifeDarja Herrmann, Horst Scherg, Rolf Verres, et al.
Bioanalysis|November 12, 2014
A high-throughput LC-MS/MS assay for quantification of artesunate and its metabolite dihydroartemisinin in human plasma and salivaSofia Birgersson, Therese Ericsson, Antje Blank, et al.
Human Reproduction (Oxford, England)|July 23, 2003
Cortisol and cortisone in human follicular fluid and serum and the outcome of IVF treatmentSabina Lewicka, Cornelia von Hagens, Ute Hettinger, et al.
Cancer Chemotherapy and Pharmacology|January 23, 2016
Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I studyMiriam König, Cornelia von Hagens, Sebastian Hoth, et al.
Cancer Chemotherapy and Pharmacology|April 21, 2016
Erratum to: Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I studyMiriam König, Cornelia von Hagens, Sebastian Hoth, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Forschende Komplementarmedizin (2006)|June 15, 2007
[Replacing the hormone replacement therapy]Cornelia von Hagens
MMW Fortschritte Der Medizin|November 26, 2008
[Alternative therapies for menopausal women]Cornelia von Hagens, Bettina Reinhard-Hennch, Thomas Strowitzki
Gynakologisch-Geburtshilfliche Rundschau|October 28, 2006
[Complementary and alternative therapies for climacteric symptoms]Bettina Reinhard-Hennch, Thomas Strowitzki, Cornelia von Hagens
European Journal of Clinical Pharmacology|September 25, 2014
Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancerTherese Ericsson, Antje Blank, Cornelia von Hagens, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 4, 2015
Developing and implementing a complex Complementary and Alternative (CAM) nursing intervention for breast and gynecologic cancer patients undergoing chemotherapy--report from the CONGO (complementary nursing in gynecologic oncology) studyNadja Klafke, Cornelia Mahler, Cornelia von Hagens, et al.
Journal of Assisted Reproduction and Genetics|September 9, 2011
Resilience in infertile couples acts as a protective factor against infertility-specific distress and impaired quality of lifeDarja Herrmann, Horst Scherg, Rolf Verres, et al.
Bioanalysis|November 12, 2014
A high-throughput LC-MS/MS assay for quantification of artesunate and its metabolite dihydroartemisinin in human plasma and salivaSofia Birgersson, Therese Ericsson, Antje Blank, et al.
Human Reproduction (Oxford, England)|July 23, 2003
Cortisol and cortisone in human follicular fluid and serum and the outcome of IVF treatmentSabina Lewicka, Cornelia von Hagens, Ute Hettinger, et al.
Cancer Chemotherapy and Pharmacology|January 23, 2016
Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I studyMiriam König, Cornelia von Hagens, Sebastian Hoth, et al.
Cancer Chemotherapy and Pharmacology|April 21, 2016
Erratum to: Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I studyMiriam König, Cornelia von Hagens, Sebastian Hoth, et al.
Pageof 2